KMDA
Kamada Ltd.
KMDA's fundamentals are strong: revenue grew 13% and earnings per share grew 15%, though free cash flow fell 16%. At 21x earnings, it's trading right at its usual valuation. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
KMDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
KMDA's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
KMDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $5.76 | -29% |
| Forward | 18x | $8.13 | — |
| Fair | 21x | $7.96 | -2.1% |
| Current | 21x | $8.13 | — |
| Expensive | 38x | $14.26 | +75% |
Historical ranges are pointers, not guarantees.
KMDA's PE is in its fair range at 21x. On analysts' estimates for next year's earnings, today's price would be 18x, in its cheap range.
KMDA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect KMDA's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
KMDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.45 | +18% |
| Q2 2026 | $0.38 | +15% |
| Q1 2026 | $0.35 | +25% |
| Q4 2025 | $0.35 | +40% |
| Q3 2025 | $0.35 | +25% |
| Q2 2025 | $0.33 | +22% |
| Q1 2025 | $0.28 | +22% |
| Q4 2024 | $0.25 | +67% |
| Q3 2024 | $0.28 | +133% |
KMDA's earnings per share have fallen from their peak: $0.38 over the past year, against $0.85 in late 2019.
KMDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $54.9M | +23% |
| Q1 2026 | $45.2M | +2.8% |
| Q4 2025 | $44.7M | +15% |
| Q3 2025 | $47M | +13% |
| Q2 2025 | $44.8M | +5.4% |
| Q1 2025 | $44M | +17% |
| Q4 2024 | $39M | +7.1% |
| Q3 2024 | $41.7M | +10% |
KMDA's revenue has grown year over year for 10 quarters in a row: $55M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +1.5 points |
| Q1 2026 | 15% | -2.3 points |
| Q4 2025 | 8% | -5.1 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 16% | +2.5 points |
| Q1 2025 | 18% | +7 points |
| Q4 2024 | 13% | +5.4 points |
| Q3 2024 | 13% | +1.2 points |
KMDA's operating margin was 17% last quarter, up 1.5 points from the same quarter a year ago.
KMDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $16M | +166% |
| Q1 2026 | -$1.3M | +$717K |
| Q4 2025 | $5M | -34% |
| Q3 2025 | $6.8M | -66% |
| Q2 2025 | $6M | -45% |
| Q1 2025 | -$2M | -$319K |
| Q4 2024 | $7.5M | +207% |
| Q3 2024 | $20.1M | +$20.9M |
KMDA generated $26M in free cash flow over the past year, down 16% from the year before.
KMDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -1.1M shares |
| 1 year | +2% | +1.1M shares |
| 3 years | +29% | +13.1M shares |
| 5 years | +24% | +11M shares |
| Available history | +39% | +16.3M shares |
KMDA has 58M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
KMDA hasn't bought back shares in the past year.
KMDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
KMDA has more cash than debt.
KMDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 41.1 | Neutral |
KMDA's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
KMDA PE vs Healthcare Sector
| Metric | KMDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 26x | 17% below |
| PE % | 52 | 29 | 23 pts above |
KMDA is trading at 21x earnings, a 17% discount to the Healthcare sector's median of 26x.
KMDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.96 | 2.1% above |
| 20 week MA | $7.81 | 4.1% above |
| 50 week MA | $7.91 | 2.8% above |
| 100 week MA | $7.44 | 9.3% above |
| 200 week MA | $6.36 | 28% above |
KMDA is in an uptrend: it's above all five of its weekly moving averages, and 28% above its 200-week average.
KMDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.84 | $6.60 | -3.5% |
| 2021 | $6.60 | $6.78 | +2.7% |
| 2022 | $6.78 | $3.92 | -42% |
| 2023 | $3.92 | $6.12 | +56% |
| 2024 | $6.12 | $5.92 | -3.3% |
| 2025 | $5.92 | $7.07 | +19% |
| 2026 YTD | $7.07 | $8.13 | +15% |
KMDA has finished lower in three of the last six years. It's up 15% so far in 2026.